Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #8,041 to #8,090.
- Octreotide injection (patient information) (1 revision)
- Octyl methoxycinnamate (1 revision)
- Octyl salicylate (1 revision)
- Ocular dominance column (1 revision)
- Ocular ischemic syndrome (1 revision)
- Ocular larva migrans (1 revision)
- Oculo skeletal renal syndrome (1 revision)
- Oculocardiac reflex (1 revision)
- Oculodentodigital syndrome (1 revision)
- Oculomotor nerve (1 revision)
- Oculomucocutaneous syndrome (1 revision)
- Oculotect (1 revision)
- Odanacatib (1 revision)
- Odd-toed ungulate (1 revision)
- Odds ratio (1 revision)
- Odom's indicator (1 revision)
- Odontoblast process (1 revision)
- Odontogenic (1 revision)
- Odontogenic keratocyst (1 revision)
- Odontogenic myxoma (1 revision)
- Odontoid fracture (1 revision)
- Odorant-binding protein (1 revision)
- Odorant-binding protein 2A (1 revision)
- Odotope theory (1 revision)
- Odulimomab (1 revision)
- Oenothera biennis (1 revision)
- Officinal (1 revision)
- Ofloxacin clinical pharmacology (1 revision)
- Ofloxacin clinical studies (1 revision)
- Ofloxacin contraindications (1 revision)
- Ofloxacin description (1 revision)
- Ofloxacin dosage and administration (1 revision)
- Ofloxacin how supplied (1 revision)
- Ofloxacin injection (patient information) (1 revision)
- Ofloxacin labels and packages (1 revision)
- Ofloxacin ophthalmic (patient information) (1 revision)
- Ofloxacin otic (patient information) (1 revision)
- Ogden Lindsley (1 revision)
- Ogilvie syndrome (patient information) (1 revision)
- Ogilvie syndrome MRI (1 revision)
- Ogilvie syndrome case study one (1 revision)
- Ogilvie syndrome cost-effectiveness of therapy (1 revision)
- Ogilvie syndrome future or investigational therapies (1 revision)
- Ogilvie syndrome secondary prevention (1 revision)
- Oguchi disease (1 revision)
- Ohio University (1 revision)
- Ohm's law (1 revision)
- Ohmefentanyl (1 revision)
- Oil bath (1 revision)
- Oil of guaiac (1 revision)